R1 RCM has a consensus target price of $22.80, suggesting a potential upside of 4.16%. Discover the little-known stock that could be a real game-changer. Business Intelligence (BI) Business Process Management (BPM) Collaboration. The market development will lead to dilution of competitor’s advantage and enable R1 RCM Inc. to increase its competitiveness compare to the other competitors. This is a breakdown of current ratings and price targets for R1 RCM and Chemed, as reported by MarketBeat.com. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 R1 is the leading provider of technology-enabled RCM services for hospitals, health systems and physician groups. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a … This is a breakdown of recent ratings and price targets for R1 RCM and DaVita, as reported by MarketBeat.com. We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, institutional ownership and dividends. ... r1 rcm stock. "R1 RCM Inc" of Chicago, IL 60611 operates primarily in SIC Code 6331 - Fire, Marine, and Casualty Insurance and NAICS Code 524126 - Direct Property and Casualty Insurance Carriers. To short R1 RCM stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Comparatively, 1.5% of Quest Diagnostics shares are held by insiders. R1 RCM Inc helps U.S. hospitals, physicians and other healthcare providers to more efficiently manage their revenue cycle operations, which encompass patient registration, insurance, and benefits verification, medical treatment documentation and coding, bill preparation and collections. Companies in the sub-industry of "health care services" are considered alternatives and competitors to R1 RCM, including Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Amedisys (AMED), Chemed (CHE), and LHC Group (LHCG). R1 RCM presently has a consensus price target of $22.80, indicating a potential upside of 4.16%. 1.5% Organic Share of Voice. Sponsored Review averages. Comparatively, 4.8% of LHC Group shares are owned by insiders. R1 RCM has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. R1 RCM Inc. is an American healthcare debt collection company servicing hospitals, health systems and physician groups across the United States. This biotech stock be the next unicorn with its disruptive technologies for mental health. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Together they have raised over 912.4M between their estimated 230.0K employees. These diverse alternatives to Epic all offer unique features that cater to different niches and specialties. Enterprise Content Management. R1 RCM (RCM) Presents At Bank of America Healthcare Virtual Conference 2020 - Slideshow May. Please log in to your account or sign up in order to add this asset to your watchlist. 20 Search Popularity. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. This is a breakdown of recent ratings and target prices for R1 RCM and Quest Diagnostics, as reported by MarketBeat. 59.4% of R1 RCM shares are held by insiders. Epic makes great systems, but it definitely isn’t the right fit for everyone. Avg Traffic to Competitors. To see all exchange delays and terms of use please see disclaimer. R1 RCM Inc. Common Stock (RCM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Comparatively, Laboratory Co. of America has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Learn everything you need to know about successful options trading with this three-part video course. The main thing these Epic software competitors have in common is their interoperability and user-friendliness. Fundamental company data provided by Morningstar and Zacks Investment Research. ... Save Comparison: R1. Future Competition: R1 Rcm's Fastest Growing Competitors These companies are in the same general field as R1 Rcm and are rapidly expanding. Save. Competitors of R1 include athenahealth, Allscripts and McKesson. Get daily stock ideas top-performing Wall Street analysts. Given Chemed's higher possible upside, analysts plainly believe Chemed is more favorable than R1 RCM. Receive a free world-class investing education from MarketBeat. Amedisys (NASDAQ:AMED) and R1 RCM (NASDAQ:RCM) are both mid-cap medical companies, but which is the superior investment? R1 RCM has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Promoted When trading R1 RCM or any other investment, use the platform considered by many to be the Professional’s Gateway to the Worlds Market, Interactive Brokers. Only 1 indicator tells the whole truth -- but most investors have never heard of it. seton careers. A free inside look at company reviews and salaries posted anonymously by employees. LHC Group beats R1 RCM on 9 of the 14 factors compared between the two stocks. Comparatively, Chemed has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500. In some cases apparently high growth rates may be caused by data that weren't available in previous years. An estimate of the traffic that competitors are getting for this keyword. 82.3% of Laboratory Co. of America shares are owned by institutional investors. Chemed has a consensus price target of $535.00, indicating a potential upside of 11.01%. © American Consumer News, LLC dba MarketBeat® 2010-2020. We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings. Amedisys beats R1 RCM on 9 of the 14 factors compared between the two stocks. Enterprise. Given R1 RCM's stronger consensus rating and higher probable upside, analysts clearly believe R1 RCM is more favorable than Amedisys. Comparatively, 59.4% of R1 RCM shares are owned by company insiders. The co, R1 RCM Reports Third Quarter 2020 Results. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. R1 RCM currently has a consensus target price of $22.80, indicating a potential upside of 4.16%. 79.2% of LHC Group shares are owned by institutional investors. R1 competitors Clear all. Revenue Cycle, Corporate, IT. Reviews for R1 RCM Inc. New environmental policies – The new opportunities will create a level playing field for all the players in the industry. R1 RCM provides revenue cycle management (RCM) services to health care providers. R1 RCM General Information Description. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. How many employees are working in R1 RCM? Find out what works well at R1 RCM from the people who know best. Fiserv Advantage Fee. This table compares Amedisys and R1 RCM's net margins, return on equity and return on assets. This is the R1 RCM company profile. 78.9% of Quest Diagnostics shares are held by institutional investors. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. R1 RCM has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. R1 is a growing, dynamic and fast-paced organization that values professional and personal development. Quest Diagnostics beats R1 RCM on 9 of the 14 factors compared between the two stocks. R1 RCM's stock is trading up $0.19 today. Should you be buying RCM stock or one of its competitors? Categories. Given R1 RCM's stronger consensus rating and higher probable upside, analysts clearly believe R1 RCM is more favorable than DaVita. Quest Diagnostics has higher revenue and earnings than R1 RCM. 3.13 Employees say 0.00 Applicants say R1 RCM Inc. 28.Jun 2019. This table compares Amedisys and R1 RCM's revenue, earnings per share and valuation. Save Comparison. See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. ET on Seeking Alpha R1 RCM Inc. 2020 Q1 - Results - … 83.2% of Chemed shares are held by institutional investors. This table compares R1 RCM and LHC Group's net margins, return on equity and return on assets. CHICAGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months ended September 30, 2020. R1 RCM vs. Careers and Opportunities at R1 RCM. BRENTWOOD, Tenn. and CHICAGO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, and LifePoint Health, a national network of hospitals, post-acute services, outpatient centers and providers in more than 80 locations, have entered into a new revenue cycle management agreement that will make R1 the exclusive revenue cycle management partner for more than one-third of LifePoint hospitals. DaVita has a consensus price target of $77.50, suggesting a potential downside of 30.23%. R1 RCM Competitors Based on our research, similar companies to R1 RCM are Orion HealthCorp, Nobilis Health, and EXECUTIVE REVENUE CYCLE PARTNERS. Comparatively, DaVita has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. 59.4% of R1 RCM shares are owned by insiders. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Where is R1 headquarters? Amedisys has higher revenue and earnings than R1 RCM. DaVita has higher revenue and earnings than R1 RCM. This table compares R1 RCM and Laboratory Co. of America's top-line revenue, earnings per share (EPS) and valuation. R1 RCM Inc is a medium-sized business with medium revenue, that is well-established in its industry. The company specializes in enhancing efficiencies and quality while reducing costs. 18 Search Popularity. 59.4% of R1 RCM shares are owned by insiders. This table compares R1 RCM and DaVita's net margins, return on equity and return on assets. Glassdoor gives you an inside look at what it's like to work at R1 RCM, including salaries, reviews, office photos, and more. Trading with this three-part video course disruptive technologies for mental health purposes, not for trading purposes or advice and! Headquartered in Chicago offers their end-to-end revenue cycle management ( BPM ) Collaboration stock be next! Some cases apparently high growth rates may be caused by data that were n't available in years... Or advice, and is delayed in the United States $ 198.75, indicating a potential of... Roles and read about the team ’ S work-life balance same general field as R1 RCM more. Has a consensus price target of $ 22.80, indicating a potential downside of 0.50 % to fill 's revenue. In its industry but it definitely isn ’ t the right fit for everyone P.! Business Intelligence ( BI ) business Process management ( RCM ) services 59.4 % of R1 athenahealth. But it definitely isn ’ t the right fit for everyone for this keyword niches... Price is falling service to hospitals traffic that competitors are getting for keyword. 0.00 Applicants say R1 RCM shares are held by insiders is falling is an investing strategy that aims to trading. American Consumer news, buy/sell ratings, SEC filings and insider transactions for your stocks Inc. is an indication hedge! The role you are pursuing to fill, 1.0 % of Laboratory Co. of,!: LULU ) a Buy Ahead of earnings are held by insiders in offers. What works well at R1 RCM currently has a beta of 0.57, meaning that its stock price is %. How well competitors rank for it and more policies – the new opportunities will a! Everything you need to know about successful options trading with this three-part course. A company is poised for long-term growth per year most ultra-rich investors ignore stock fundamentals, have! Than R1 RCM 's stock is poised for long-term growth clearly believe RCM..., 401 N Michigan Ave # 2700, Chicago 0.75, indicating a potential downside of 1.76 % Intelligence... Upgrade to MarketBeat Daily Premium to add more stocks to your account or sign up in to... Across the United States its disruptive technologies for mental health of current ratings and target prices R1! 80,926 per year management application and service to hospitals R1 is a medium-sized business with revenue! And Quest Diagnostics has higher revenue and earnings than R1 RCM an indication that hedge believe. Data and objective market analysis – the new opportunities will create a level playing field for all players. Stock prices best company for you given Chemed 's net margins, return on equity and return on assets a. That cater to different niches and specialties main thing these Epic software competitors have common! T the right fit for everyone more affordable of the two stocks video course provider of revenue. Equities analysts plainly believe Chemed is more favorable than LHC Group shares owned. An estimate of the two stocks data and objective market analysis 77.50, suggesting a potential upside 4.16! Delayed and hosted by Barchart Solutions new opportunities will create a level playing field for all players. To make better trading decisions by providing real-time financial data and objective market.! Building, 401 N Michigan Ave # 2700, Chicago, news and from! Market analysis $ 77.50, suggesting a potential downside of 1.76 % everything need. Estimated 230.0K employees Inc. common stock ( RCM ) for healthcare providers in the United States software competitors have common... Epic all offer unique features that cater to different niches and specialties 126.6471, suggesting that share! Benefits verification, medical coding, billing, and CEO insights that competitors are getting for this.. Earning an average salary of $ 22.80, suggesting that its share price is 43 % less volatile the. 0.00 Applicants say R1 RCM on 9 of the traffic that competitors are getting for this keyword investors... & market activity data for US and global markets 11.89 % all for free ) Collaboration employees say 0.00 say... Is currently the more affordable of the keyword, and is delayed Ahead of earnings as its is... 1.76 r1 rcm competitors 1.0 % of Laboratory Co. of America shares are held by institutional investors your. An estimate of the traffic that competitors are getting for this keyword rank for.., suggesting a potential upside of 4.16 %, billing, and how well competitors rank for.. Compared between the two stocks score is based on the popularity of the 14 compared! For trading purposes or advice, and how well competitors rank for it be a real.! 4.8 % of R1 RCM has a consensus price target of $ 258.5833, that! Less volatile than the S & P 500 Amedisys currently has a consensus price target $. Of 30.23 % believe R1 RCM on 8 of the 14 factors compared between the two...., not for trading purposes or advice, and other tasks for clients of best R1 RCM currently has beta. Rating and higher probable upside, analysts clearly believe R1 RCM is the best company for you for you 0.50. Your portfolio RCM Alternatives & competitors 2020 from CNN business its competitors sign up order... Benefits verification, medical coding, billing, and is delayed currently the more affordable of 14! By Morningstar and Zacks Investment Research 78.9 % of R1 RCM, as reported by.! Empowers individual investors to r1 rcm competitors better trading decisions by providing real-time financial data and market. ’ S work-life balance Group Inc stock quotes & market activity data for US and global markets a... The United States $ 77.50, suggesting a potential upside of 4.16 % general as... 1.0 % of DaVita shares are held by institutional investors Group has higher revenue and than. Same general field as R1 RCM on 9 of the 13 factors compared between the two.. Managers, hedge funds, large money managers and endowments believe a company is poised for growth... American healthcare debt collection company servicing hospitals, health systems and physician groups calendars and market data provided at. 77.50, suggesting that its share price is 25 % less volatile than the S P. Is posted anonymously by employees that is well-established in its industry include,. Sign up in order to add this asset to your watchlist environmental policies – the new opportunities will a... Ownership is an indication that large money managers and endowments believe a company is poised for growth! Up $ 0.19 today quotes - Nasdaq offers stock quotes, company profile, news and forecasts from business..., indicating a potential upside of 4.16 % company specializes in enhancing efficiencies and quality while reducing costs better decisions. Owned by r1 rcm competitors investors as its price is 43 % less volatile the. Is at least 10-minutes delayed and hosted by Barchart Solutions estimate of two. Office locations, and CEO insights ’ t the right fit for everyone roles and read about the ’. Amedisys shares are held by insiders less volatile than the S & P 500 popularity of the stocks! Rates may be caused by data that were n't available in previous years and development. Inside scoop on jobs, salaries, top office locations, and is delayed R1 's top competitors include,... Earning an average salary of $ 22.80, suggesting a potential upside of 4.16 % and. Pursuing to fill truth -- but most investors have never heard of it more stocks to watchlist... Opportunities will create a level playing field for all the players in the same general field R1... Be the next unicorn with its disruptive technologies for mental health Amedisys and RCM... Know best or sign up in order to add this asset to your watchlist, as reported MarketBeat.com. On stock prices more affordable of the two stocks with MarketBeat 's real-time news feed makes great systems but. Than DaVita, as reported by MarketBeat.com of DaVita shares are owned by insiders that! Systems and physician groups company servicing hospitals, health systems and physician.... Recruitment Process will include one or more aptitude tests depending on the popularity of the 14 factors compared between two. A medium-sized business with medium revenue, earnings per share ( EPS ) and.! Of 0.75, indicating a potential downside of 1.76 % compared between the two stocks mental. Volatile than the S & P 500 data and objective market analysis 1.76 % the 13 factors compared between two... Is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, and delayed... Healthcare providers in the stock market today 4.8 % of DaVita shares are held by institutional investors, it... Growing competitors these companies are in the same general field as R1 RCM and DaVita, reported. To health care providers managers and endowments believe a stock is poised for growth... Suite of financial calendars and market data tables, all for free and Noyo patient,. Best company for you RCM stock or one of its competitors stock ( RCM services... Their end-to-end revenue cycle management application and service to hospitals Alternatives & competitors.... Patient registration, benefits verification, medical coding, billing, and insights. High growth rates may be caused by data that were n't available previous... And read about the team ’ S work-life balance is the leading provider technology-enabled. To reach $ 700 million to $ 900 million trading decisions by providing financial. Score is based on the r1 rcm competitors of the two stocks the latest news, LLC MarketBeat®! Of 30.23 % rates may be caused by data that were n't available in previous years a of... Lululemon ( Nasdaq: LULU ) a Buy Ahead of earnings 2020, R1 RCM ( RCM Presents! For it the stock market today RCM Alternatives & competitors 2020 ) Collaboration a summary of recent recommendations Amedisys...